Home
Resources
Product Analysis
Acknowledgements
About
Home
References
Biotech components
Biotech components
Virus
Products 1 to 8 of 8
Modify Display Properties
Biotech components
Business models
Country of production
Country of distribution
Intended consumer
Date added
Date last modified
Known funding amount
Funding types
Industry
Market status
Organization
Organization type(s)
Product categories
Production process
Source
Trading symbol
Value chain stage
Sort: Title (A-Z)
Date added (oldest-newest)
Date added (newest-oldest)
Date modified (oldest-newest)
Date modified (newest-oldest)
Title (A-Z)
Title (Z-A)
Organization (A-Z)
Organization (Z-A)
Attenuated Virus Cultures for Vaccine Production
by
J. Craig Venter
Biotech components:
Virus
Business models:
B2B
Country of production:
USA
Country of distribution:
N/A
Intended consumer:
Commercial
+
Government
Date added:
2018/08/30 11:49 (5 years ago)
Date last modified:
2018/08/30 11:49 (5 years ago)
Known funding amount:
27,400,000 USD
Funding types:
Research Institution
Industry:
Health
Market status:
Under Development
Organization type(s):
University
+
Research Institution
Product categories:
Medical Treatment
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
N/A
Value chain stage:
Input
Bacteriophage Treatment
by
MIT
Biotech components:
Virus
Business models:
B2C
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Commercial
+
Government
Date added:
2018/08/30 11:49 (5 years ago)
Date last modified:
2018/08/30 11:49 (5 years ago)
Known funding amount:
N/A
Funding types:
Private Funding
Industry:
Health
Market status:
Under Development
Organization type(s):
University
+
Research Institution
Product categories:
Medical Treatment
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
N/A
Value chain stage:
Finished Product
COVID-19 Antibody Treatment
by
Adagio
Biotech components:
Virus
Business models:
B2C
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2020/12/18 14:39 (3 years ago)
Date last modified:
2020/12/18 14:39 (3 years ago)
Known funding amount:
50,000,000 USD
Funding types:
Private Funding
Industry:
Medical
Market status:
Under Development
Organization type(s):
Private Company
Product categories:
Medicine
Production process:
N/A
Source:
Web search
Trading symbol:
N/A
Value chain stage:
Input
crPhage
by
Locus Biosciences
Biotech components:
Gene Editing
+
Molecule
+
Virus
Business models:
B2C
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2019/09/12 15:10 (4 years ago)
Date last modified:
2019/09/12 15:10 (4 years ago)
Known funding amount:
N/A
Funding types:
Private Funding
+
Shareholder Investment
Industry:
Health
+
Medical
Market status:
Under Development
Organization type(s):
Public Company
Product categories:
Medical Treatment
+
Medicine
Production process:
N/A
Source:
Web search
Trading symbol:
N/A
Value chain stage:
Finished Product
Genetic Circuits
by
MIT
Biotech components:
Virus
Business models:
B2B
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Research
Date added:
2018/08/30 11:49 (5 years ago)
Date last modified:
2018/08/30 11:49 (5 years ago)
Known funding amount:
N/A
Funding types:
Private Funding
Industry:
Health
Market status:
Under Development
Organization type(s):
University
+
Research Institution
Product categories:
Medical Treatment
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
N/A
Value chain stage:
Input
INXN-3004: AML
by
Intrexon
Biotech components:
Virus
Business models:
B2B
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2020/02/10 09:59 (4 years ago)
Date last modified:
2020/02/10 09:59 (4 years ago)
Known funding amount:
N/A
Funding types:
Shareholder Investment
Industry:
Medical
Market status:
Under Development
Organization type(s):
Public Company
Product categories:
Medical Treatment
Production process:
N/A
Source:
Web search
Trading symbol:
XON
(NASDAQ)
Value chain stage:
Finished Product
Sleeping Beauty
by
Ziophram
Biotech components:
Virus
Business models:
B2C
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (5 years ago)
Date last modified:
2018/08/30 11:49 (5 years ago)
Known funding amount:
182,600,000 USD
Funding types:
Shareholder Investment
Industry:
Health
Market status:
Under Development
Organization type(s):
Public Company
Product categories:
Medicine
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
ZIOP
(NASDAQ)
Value chain stage:
Finished Product
SNS-301 (noninfectious lambda bacteriophage viruses)
by
Sensei Biotherapeutics
Biotech components:
Virus
Business models:
B2C
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2020/12/18 14:40 (3 years ago)
Date last modified:
2020/12/18 14:40 (3 years ago)
Known funding amount:
28,500,000 USD
Funding types:
Private Funding
Industry:
Medical
Market status:
Under Development
Organization type(s):
Private Company
Product categories:
Medical Treatment
+
Medicine
Production process:
N/A
Source:
Web search
Trading symbol:
N/A
Value chain stage:
Input
Login
or
register
to add and edit products
Future
Bioengineered
Products
Home
Resources
Product Analysis
Acknowledgements
About
